Theravance Biopharma (TBPH) SVP Brett Grimaud Withholds 8,829 Shares

What Happened

• Brett A. Grimaud, SVP, General Counsel and Secretary of Theravance Biopharma, had 8,829 restricted stock units (RSU) withheld on May 20, 2026, to satisfy tax obligations. The withholding was at $16.55 per share, totaling $146,120. This was a tax-withholding disposition (code F), not an open-market sale.

Key Details

• Transaction date: 2026-05-20; filing date: 2026-05-22 (filed within the standard Form 4 window).
• Withheld shares: 8,829 at $16.55 each; total value $146,120.
• Transaction code: F — tax withholding to cover taxes on vested RSUs.
• Footnote: Shares were withheld by the issuer to satisfy tax obligations from previously granted RSUs; no open market transaction occurred.
• Shares owned after transaction: Not disclosed in the supplied filing.

Context

• Tax-withholding on RSU vesting is a routine, non-market transaction and does not necessarily indicate the insider's view on the company. Withheld shares are typically used to cover payroll/tax liabilities and are not the same as an open-market sale.